Warning against co-administration of 3,4-methylenedioxymethamphetamine (MDMA) with methamphetamine from the perspective of pharmacokinetic and pharmacodynamic evaluations in rat brain

European Journal of Pharmaceutical Sciences

Volumn 49, Issue 1, 2013, Pages 57-64

  Yuki, Fuchigami ^a   Rie, Ikeda ^a   Miki, Kuzushima ^a   Mitsuhiro, Wada ^a   Naotaka, Kuroda ^a   Kenichiro, Nakashima ^a,b  

^a NAGASAKI UNIVERSITY   (Japan)

^b NAGASAKI INTERNATIONAL UNIVERSITY   (Japan)

Author keywords

3,4 Methylenedioxymethamphetamine; Interaction; Methamphetamine; Pharmacodynamics; Pharmacokinetics; Risk evaluation

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; DOPAMINE; METHAMPHETAMINE; MONOAMINE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN LEVEL; CORPUS STRIATUM; DIALYSATE; DRUG DISTRIBUTION; DRUG EXPOSURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; JAPAN; MALE; MONOAMINE RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; BRAIN; DRUG EFFECTS; INTRAPERITONEAL DRUG ADMINISTRATION; METABOLISM; WISTAR RAT;

ANIMALS; BRAIN; INJECTIONS, INTRAPERITONEAL; MALE; METHAMPHETAMINE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RATS; RATS, WISTAR;

EID: 84874943830     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2013.01.014     Document Type: Article

References (42)

1. T. Chu, Y. Kumagai, E.W. DiStefano, and A.K. Cho Disposition of methylenedioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion Biochem. Pharmacol. 51 1996 789 796 (Pubitemid 26094447)
2. K.J. Clemens, P.S. van Nieuwenhuyzen, K.M. Li, J.L. Cornish, G.E. Hunt, and I.S. McGregor MDMA ("ecstasy"), methamphetamine and their combination: long-term changes in social interaction and neurochemistry in the rat Psychopharmacology 173 2004 318 325 (Pubitemid 38703805)
3. K.J. Clemens, J.L. Cornish, K.M. Li, G.E. Hunt, and I.S. McGregor MDMA ("ecstasy"), methamphetamine and their combination: order of administration influences hyperthermic and long-term adverse effects in female rats Neuropharmacol 49 2005 195 207 (Pubitemid 40933758)
4. J.C. Cole, and H.R. Sumnall The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA) Neurosci. Biobehav. Rev. 27 2003 199 217 (Pubitemid 36677429)
5. C. Cordon-Cardo, J.P. O'Brien, D. Casals, L. Rittman-Grauer, J.L. Biedler, M.R. Melamed, and J.R. Bertino Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites Proc. Natl. Acad. Sci. USA 86 1989 695 698 (Pubitemid 19037807)
6. J.R. Docherty, and A.R. Green The role of monoamines in the changes in body temperature induced by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its derivatives Br. J. Pharmacol. 160 2010 1029 1044
7. H.C. Fox, A. McLean, J.J.D. Turner, A.C. Parrott, R. Rogers, and B.J. Sahakian Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users Psychopharmacology 162 2002 203 214 (Pubitemid 34743960)
8. E. Gouzoulis-Mayfrank, and J. Daumann Neurotoxicity of drug of abuse-the case of methylenedioxyamphetamine (MDMA, ecstasy), and amphetamines Dialogues Clin. Neurosci. 11 2009 305 317
9. S.L. Greene, P.I. Dargan, N. O'connor, A.L. Jones, and M. Kerins Multiple toxicity from 3,4-methylenedioxymethamphetamine ("Ecstasy") Am. J. Emerg. Med. 21 2003 121 124
10. A.P. Hall, and J.A. Henry Acute toxic effects of 'Ecstasy' (MDMA) and related compounds: overview of pathophysiology and clinical management Br. J. Anaesth. 96 2006 678 685 (Pubitemid 43786681)
11. D.D. Han, and H.H. Gu Comparison of the monoamine transporters from human and mouse in there sensitivities to psychostimulant drugs BMC Pharmacol. 6 2006 6 12
12. R. Ikeda, Y. Igari, Y. Fuchigami, M. Wada, N. Kuroda, and K. Nakashima Pharmacodynamic interactions between MDMA and concomitants in MDMA tablets on extracellular dopamine and serotonin in the rat brain Eur. J. Pharmacol. 660 2011 318 325
13. R.J. Irvine, M. Keane, P. Felgate, U.D. McCann, P.D. Callaghan, and J.M. White Plasma drug concentrations and physiological measures in 'dance party' participants Neuropsychopharmacol. 31 2006 424 430 (Pubitemid 43113406)
14. S. Kaye, S. Darke, and J. Duflou Methylenedioxymethamphetamine (MDMA)-related fetelities in Australia: demographics, circumstances, toxicology and major organ pathology Drug Alchol Depend. 104 2009 254 261
15. N. Ketabi-Kiyanvash, J. Weiss, W.E. Haefeli, and G. Mikus P-glycoprotein modulation by the designer drugs methylenedioxymethamphetamine, methylenedioxyethylamphetamine and paramethoxyamphetamine Addict. Biol. 8 2003 413 418 (Pubitemid 38102047)
16. E.A. Kolbrich, R.S. Goodwin, D.A. Gorelick, R.J. Hayes, E.A. Stein, and M.A. Huestis Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults Ther. Drug Monit. 30 2008 320 332
17. R. la de Torre, M. Farre, J. Ortuno, S. Mas, R. Brennieisen, P.N. Roset, J. Segura, and J. Cami Non-linear pharmacokinetics of MDMA ('ecstasy') in humans Br. J. Clin. Pharmacol. 49 2000 104 109 (Pubitemid 30068287)
18. J. Lyles, and J.L. Cadet Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms Brain Res. Rev. 42 2003 155 168 (Pubitemid 36549174)
19. Y. Makino, S. Tanaka, S. Kurobane, M. Nakauchi, T. Terasaki, and S. Ohta Profiling of illegal amphetamine-type stimulant tablets in Japan J. Health Sci. 49 2003 129 137 (Pubitemid 41301480)
20. H. Mann, B. Ladenheim, H. Hirata, T.H. Moran, and J.L. Cadet Differential toxic effects of methamphetamine (METH) and methylenedioxymethamphetamine (MDMA) in multidrug-resistant (mdr 1a) knockout mice Brain Res. 769 1997 340 346 (Pubitemid 27461470)
21. U.D. McCann, and G.A. Ricaurte Caveat emptor: editors beware Neuropsychopharmacology 24 2001 333 334
22. A.O. Mechan, B. Esteban, E. O'Shea, J.M. Elliott, M.I. Colado, and A.R. Green The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats Br. J. Pharmacol. 135 2002 170 180 (Pubitemid 34102110)
23. K.M. Morefield, M. Keane, P. Felgate, J.M. White, and R.J. Irvine Pill content, dose and resulting plasma concentrations of 3,4- methylenedioxymethamphetamine (MDMA) in recreational 'ecstasy' users Addiction 106 2011 1293 1300
24. M. Mueller, F.T. Peters, H.H. Maurer, U.D. McCann, and G.A. Ricaurte Nonlinear pharmacokinetics of (±)3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") and its major metabolites in squirrel monkeys at plasma concentrations of MDMA that develop after typical psychoactive doses J. Pharmacol. Exp. Ther. 327 2008 38 44
25. K. Nakashima, H. Yamasaki, N. Kuroda, and S. Akiyama Evaluation of lophine derivatives as chemiluminogens by a flow-injection method Anal. Chim. Acta 303 1995 103 108
26. National Police Agency of Japan., 2011. The White Paper on POLICE 2011. National Police Agency, Tokyo, Japan.
27. National Institute on Drug Abuse (NIDA), 2006a. Research Report Series MDMA(ECSTASY). NIH, Publication Number 06-4728.
28. National Institute on Drug Abuse (NIDA), 2006b. Research Report Series METHAMPHETAMINE. NIH, Publication Number 06-4210.
29. Y. Numachi, A. Ohara, M. Yamashita, S. Fukushima, H. Kobayashi, H. Hata, H. Watanabe, F.S. Hall, K.P. Lesch, D.L. Murphy, G.R. Uhl, and I. Sora Methamphetamine-induced hyperthermia and lethal toxicity: role of the dopamine and serotonin transporters Eur. J. Pharmacol. 572 2007 120 128 (Pubitemid 47429639)
30. D. Pal, and A.K. Mitra MDR- and CYP3A4-mediated drug-drug interactions J. Neuroimmune Pharmacol. 1 2006 323 339 (Pubitemid 44244137)
31. G. Paxinos, and G. Watson The Rat Brain in Stereotaxic Coordinates fifth ed. 2007 Academic Press California
32. M.S. Quinton, and B.K. Yamamoto Causes and consequences of methamphetamine and MDMA toxicity AAPS J. 8 2006 E337 347
33. R. Sano, T. Hasuike, M. Nakano, Y. Kominato, and H. Itoh A fatal case of myocardial damage due to misuse of the "designer drug" MDMA Leg. Med. 11 2009 294 297
34. E. Silins, J. Copeland, and P. Dillon Patterns and harms of pharmaceutical drug use among ecstasy users in Australia Adicciones 21 2009 347 362
35. Y. Sun, M.N. Nakashima, M. Takahara, N. Kuroda, and K. Nakashima Determination of bisphenol A in rat brain by microdialysis and column switching high-performance liquid chromatography with fluorescence detection Biomed. Chromatogr. 16 2002 319 326 (Pubitemid 34982343)
36. F. Teng, S. Wu, C. Liu, J. Li, and C. Chien Characteristics and trends of 3,4-methylenedioxymethamphetamine (MDMA) tablets found in Taiwan from 2002 to February 2005 Forensic Sci. Int. 161 2006 202 208 (Pubitemid 44142909)
37. The PubChem Project: < http://pubchem.ncbi.nlm.nih.gov > (accessed 19.12.12).
38. D.M. Tohmas, M.A. Perez, D.M. Francescutti-Verbeem, M.M. Shah, and D.M. Kuhn The role of endogenous serotonin in methamphetamine-induced neurotoxicity to dopamine nerve endings of the striatum J. Neurochem. 115 2010 595 605
39. M. Tomita, N.M. Nakashima, M. Wada, and K. Nakashima Sensitive determination of MDMA and its metabolite MDA in rat blood and brain microdialysates by HPLC with fluorescence detection Biomed. Chromatogr. 21 2007 1016 1022 (Pubitemid 47490311)
40. S.L. Verheyden, J.A. Henry, and V.H. Curran Acute, sub-acute and long-term subjective consequences of 'ecstasy' (MDMA) consumption in 430 regular users Hum. Psychopharmacol. 18 2003 507 517 (Pubitemid 37279232)
41. M. Wada, C. Yokota, Y. Ogata, N. Kuroda, H. Yamada, and K. Nakashima Sensitive HPLC-fluorescence detection of morphine labeled with DIB-Cl in rat brain and blood microdialysates and its application to the preliminarily study of the pharmacokinetic interaction between morphine and diclofenac Anal. Bioanal. Chem. 391 2008 1057 1062
42. K. Yamaoka, T. Nakagawa, and T. Uno Statistical moments in pharmacokinetics J. Pharmacokinet. Biop. 6 1978 547 558